Literature DB >> 27824288

Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.

Alyaksandr V Nikitski1, Tatiana I Rogounovitch1, Andrey Bychkov1, Meiko Takahashi2, Koh-Ichiro Yoshiura3, Norisato Mitsutake1,4, Takahisa Kawaguchi5, Michiko Matsuse1, Valentina M Drozd6, Yuri Demidchik7, Eijun Nishihara8, Mitsuyoshi Hirokawa8, Akira Miyauchi8, Alexander V Rubanovich9,10, Fumihiko Matsuda5, Shunichi Yamashita1,10, Vladimir A Saenko10.   

Abstract

BACKGROUND: Several functional single-nucleotide polymorphisms (SNPs) at the FOXE1 locus on chromosome 9q22.33 have been associated with the risk for papillary thyroid carcinoma (PTC). This study set out to elucidate whether their effects are independent, using genotyping results in populations of Asian and European descent.
METHODS: SNPs rs965513 and rs1867277 and a polymorphic region determining the length of the FOXE1 polyalanine (poly-Ala) tract were genotyped in 501 patients with PTC and 748 healthy individuals from Japan, and in 660 patients and 820 population controls from Belarus. Functional analysis of transactivation activities of FOXE1 isoforms with varying number of alanine repeats was performed by a Dual-Luciferase® Assay.
RESULTS: All three polymorphisms were significantly associated with PTC in both populations on univariate analysis. However, conditional analysis revealed independent effects of rs965513 and rs1867277 SNPs but not of the FOXE1 poly-Ala polymorphism. The independent effect of the lead rs965513 SNP was observed in both populations, while that of rs1867277 was only identified in the Japanese population, in which linkage disequilibrium between the three polymorphisms is markedly weaker. Despite the strong decrease in transcriptional activity with increasing FOXE1 poly-Ala tract length, no difference in transactivation potential of the FOXE1 poly-Ala isoforms could be seen after adjustment for the minimal promoter activity in the reporter vectors. Plasmids encoding FOXE1 isoforms of increasing poly-Ala tract length were also found to produce less FOXE1 protein after cell transfection.
CONCLUSIONS: The functional variants rs965513 and rs1867277 independently contribute to genetic predisposition to PTC, while a contributing role of the FOXE1 poly-Ala polymorphism could not be confirmed.

Entities:  

Keywords:  FOXE1 polymorphism; case-control association study; functional analysis of transactivation potential; genotype; papillary thyroid carcinoma

Mesh:

Substances:

Year:  2016        PMID: 27824288     DOI: 10.1089/thy.2015.0541

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  8 in total

1.  Lessons from Fukushima: Latest Findings of Thyroid Cancer After the Fukushima Nuclear Power Plant Accident.

Authors:  Shunichi Yamashita; Shinichi Suzuki; Satoru Suzuki; Hiroki Shimura; Vladimir Saenko
Journal:  Thyroid       Date:  2017-12-01       Impact factor: 6.568

Review 2.  Genetic Polymorphism Predisposing to Differentiated Thyroid Cancer: A Review of Major Findings of the Genome-Wide Association Studies.

Authors:  Vladimir A Saenko; Tatiana I Rogounovitch
Journal:  Endocrinol Metab (Seoul)       Date:  2018-06

3.  The Contribution of Genetic Variants to the Risk of Papillary Thyroid Carcinoma in the Kazakh Population: Study of Common Single Nucleotide Polymorphisms and Their Clinicopathological Correlations.

Authors:  Zhanna Mussazhanova; Tatiana I Rogounovitch; Vladimir A Saenko; Ainur Krykpayeva; Maira Espenbetova; Bauyrzhan Azizov; Hisayoshi Kondo; Katsuya Matsuda; Zhanna Kalmatayeva; Raushan Issayeva; Zhanar Yeleubayeva; Madina Madiyeva; Aray Mukanova; Marat Sandybayev; Saltanat Bolsynbekova; Zhanna Kozykenova; Shunichi Yamashita; Masahiro Nakashima
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-22       Impact factor: 5.555

Review 4.  Emerging Biomarkers in Thyroid Practice and Research.

Authors:  Shipra Agarwal; Andrey Bychkov; Chan-Kwon Jung
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 5.  Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys.

Authors:  María Sánchez-Ares; Soledad Cameselle-García; Ihab Abdulkader-Nallib; Gemma Rodríguez-Carnero; Carolina Beiras-Sarasquete; José Antonio Puñal-Rodríguez; José Manuel Cameselle-Teijeiro
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-28       Impact factor: 5.555

Review 6.  Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer.

Authors:  Fabíola Yukiko Miasaki; Cesar Seigi Fuziwara; Gisah Amaral de Carvalho; Edna Teruko Kimura
Journal:  Genes (Basel)       Date:  2020-11-18       Impact factor: 4.096

7.  Network-Based Analysis Reveals Association of FOXE1 Gene Polymorphisms in Thyroid Cancer Patients; A Case-Control Study in Southeast of Iran.

Authors:  Ahmad Mehrazin; Hossein Safarpour; Seyedeh Tahmineh Davoudi; Negin Parsamanesh; Farhad Saeedi; Ebrahim Miri-Moghaddam
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01

Review 8.  Genetic Variants Associated with Thyroid Cancer Risk: Comprehensive Research Synopsis, Meta-Analysis, and Cumulative Epidemiological Evidence.

Authors:  Ran Ran; Gang Tu; Hui Li; Hao Wang; Exian Mou; Caiyang Liu
Journal:  J Oncol       Date:  2021-12-14       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.